Aktie A4043P SHINECO, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shineco, Inc.

Aktien

A4043P

US8245674085

TYHT

Verzögert Nasdaq
Andere Börsenplätze
 20:51:40 14.05.2024 		% 5 Tage % 1. Jan.
0,7989 USD +4,66 % Intraday Chart für Shineco, Inc. +0,11 % -29,05 %
20.02. Top Premarket Gainers MT
08.02. Shineco, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Shineco Regains Compliance With Nasdaq Listing Rule
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
Top Premarket Gainers
Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
Shineco, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Shineco, Inc. Announces the Appointment of Two New Executive Officers
Shineco Announces the Appointment of Two New Executive Officers
Shineco, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023
Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition
Shineco, Inc. Opens Healthy Food Restaurant with Focus on Advanced Nutrition
Shineco Plans to Boost R&D on Medical Applications of Silk Protein; Shares Rise
Shineco to Increase R&D to Explore New High-Tech Medical Product Applications
Shineco, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023
Nano-Cap Medical Watchlist (TBRIF, CLRB, AVTX, SISI)
Shineco : Acquisition/Asset Disposal - Form 8-K
Shineco, Inc. completed the acquisition of 71.42% stake in Dream Partner Limited for $17.3 million.
Shineco Unit's Cardiac Test Receives Regulatory Approval in China
Shineco Subsidiary Receives Marketing Approval from China’s Regulatory Body for its Cardiac 5-Minute Test
Shineco, Inc.'S Subsidiary, Changzhou Biowin Pharmaceutical Co., Ltd., Receives Marketing Approval from China's Regulatory Body for Its Cardiac 5 Minute Test
Shineco Enters into Cooperation Agreement with Kangling Medical to Develop New Medical Products Company
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A4043P Aktie
  4. Nachrichten Shineco, Inc.
  5. Andere Sprachen